391 related articles for article (PubMed ID: 19838201)
1. Foxo1 integrates insulin signaling with mitochondrial function in the liver.
Cheng Z; Guo S; Copps K; Dong X; Kollipara R; Rodgers JT; Depinho RA; Puigserver P; White MF
Nat Med; 2009 Nov; 15(11):1307-11. PubMed ID: 19838201
[TBL] [Abstract][Full Text] [Related]
2. Leucine supplementation increases SIRT1 expression and prevents mitochondrial dysfunction and metabolic disorders in high-fat diet-induced obese mice.
Li H; Xu M; Lee J; He C; Xie Z
Am J Physiol Endocrinol Metab; 2012 Nov; 303(10):E1234-44. PubMed ID: 22967499
[TBL] [Abstract][Full Text] [Related]
3. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.
Matsumoto M; Pocai A; Rossetti L; Depinho RA; Accili D
Cell Metab; 2007 Sep; 6(3):208-16. PubMed ID: 17767907
[TBL] [Abstract][Full Text] [Related]
4. BMI-related progression of atypical PKC-dependent aberrations in insulin signaling through IRS-1, Akt, FoxO1 and PGC-1α in livers of obese and type 2 diabetic humans.
Sajan MP; Ivey RA; Farese RV
Metabolism; 2015 Nov; 64(11):1454-65. PubMed ID: 26386696
[TBL] [Abstract][Full Text] [Related]
5. FoxO1 links hepatic insulin action to endoplasmic reticulum stress.
Kamagate A; Kim DH; Zhang T; Slusher S; Gramignoli R; Strom SC; Bertera S; Ringquist S; Dong HH
Endocrinology; 2010 Aug; 151(8):3521-35. PubMed ID: 20501674
[TBL] [Abstract][Full Text] [Related]
6. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1.
Lu M; Wan M; Leavens KF; Chu Q; Monks BR; Fernandez S; Ahima RS; Ueki K; Kahn CR; Birnbaum MJ
Nat Med; 2012 Feb; 18(3):388-95. PubMed ID: 22344295
[TBL] [Abstract][Full Text] [Related]
7. MAPK phosphatase-3 promotes hepatic gluconeogenesis through dephosphorylation of forkhead box O1 in mice.
Wu Z; Jiao P; Huang X; Feng B; Feng Y; Yang S; Hwang P; Du J; Nie Y; Xiao G; Xu H
J Clin Invest; 2010 Nov; 120(11):3901-11. PubMed ID: 20921625
[TBL] [Abstract][Full Text] [Related]
8. Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1α signaling contributing to increased vulnerability in diabetic heart.
Yan W; Zhang H; Liu P; Wang H; Liu J; Gao C; Liu Y; Lian K; Yang L; Sun L; Guo Y; Zhang L; Dong L; Lau WB; Gao E; Gao F; Xiong L; Wang H; Qu Y; Tao L
Basic Res Cardiol; 2013 May; 108(3):329. PubMed ID: 23460046
[TBL] [Abstract][Full Text] [Related]
9. Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss.
Marinho R; Ropelle ER; Cintra DE; De Souza CT; Da Silva AS; Bertoli FC; Colantonio E; D'Almeida V; Pauli JR
J Cell Physiol; 2012 Jul; 227(7):2917-26. PubMed ID: 21938726
[TBL] [Abstract][Full Text] [Related]
10. Cilostazol attenuates murine hepatic ischemia and reperfusion injury via heme oxygenase-dependent activation of mitochondrial biogenesis.
Joe Y; Zheng M; Kim HJ; Uddin MJ; Kim SK; Chen Y; Park J; Cho GJ; Ryter SW; Chung HT
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G21-9. PubMed ID: 25951827
[TBL] [Abstract][Full Text] [Related]
11. Foxo1 in hepatic lipid metabolism.
Cheng Z; White MF
Cell Cycle; 2010 Jan; 9(2):219-20. PubMed ID: 20023377
[No Abstract] [Full Text] [Related]
12. Peroxisome proliferator-activated receptor γ coactivator-1α is a central negative regulator of vascular senescence.
Xiong S; Salazar G; Patrushev N; Ma M; Forouzandeh F; Hilenski L; Alexander RW
Arterioscler Thromb Vasc Biol; 2013 May; 33(5):988-98. PubMed ID: 23430617
[TBL] [Abstract][Full Text] [Related]
13. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
[TBL] [Abstract][Full Text] [Related]
14. Heme Oxygenase-1 Regulates Ferrous Iron and Foxo1 in Control of Hepatic Gluconeogenesis.
Liao W; Yang W; Shen Z; Ai W; Pan Q; Sun Y; Guo S
Diabetes; 2021 Mar; 70(3):696-709. PubMed ID: 33408127
[TBL] [Abstract][Full Text] [Related]
15. Feedback regulation of hepatic gluconeogenesis through modulation of SHP/Nr0b2 gene expression by Sirt1 and FoxO1.
Wei D; Tao R; Zhang Y; White MF; Dong XC
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E312-20. PubMed ID: 21081708
[TBL] [Abstract][Full Text] [Related]
16. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity.
Cantó C; Gerhart-Hines Z; Feige JN; Lagouge M; Noriega L; Milne JC; Elliott PJ; Puigserver P; Auwerx J
Nature; 2009 Apr; 458(7241):1056-60. PubMed ID: 19262508
[TBL] [Abstract][Full Text] [Related]
17. Adropin regulates hepatic glucose production via PP2A/AMPK pathway in insulin-resistant hepatocytes.
Chen X; Chen S; Shen T; Yang W; Chen Q; Zhang P; You Y; Sun X; Xu H; Tang Y; Mi J; Yang Y; Ling W
FASEB J; 2020 Aug; 34(8):10056-10072. PubMed ID: 32579277
[TBL] [Abstract][Full Text] [Related]
18. Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor i/insulin signaling and caloric restriction.
Al-Regaiey KA; Masternak MM; Bonkowski M; Sun L; Bartke A
Endocrinology; 2005 Feb; 146(2):851-60. PubMed ID: 15498882
[TBL] [Abstract][Full Text] [Related]
19. FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization.
O-Sullivan I; Zhang W; Wasserman DH; Liew CW; Liu J; Paik J; DePinho RA; Stolz DB; Kahn CR; Schwartz MW; Unterman TG
Nat Commun; 2015 May; 6():7079. PubMed ID: 25963540
[TBL] [Abstract][Full Text] [Related]
20. Activation of FoxO1/ PGC-1α prevents mitochondrial dysfunction and ameliorates mesangial cell injury in diabetic rats.
Wu L; Wang Q; Guo F; Zhou Y; Ji H; Liu F; Ma X; Zhao Y; Qin G
Mol Cell Endocrinol; 2015 Sep; 413():1-12. PubMed ID: 26123583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]